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Abstract
Introduction: Surgical site infections (SSIs) are among the most common healthcare-associated infections. They are
associated with longer post-operative hospital stays, additional surgical procedures, risk of treatment in intensive
care units and higher mortality.
Material and methods: SSIs were detected in patients hospitalized in a 40-bed orthopaedics ward in 2009–2018.
The total number of study patients was 15,678. The results were divided into two 5-year periods before and after
the introduction of the SSI prevention plan. The study was conducted as part of a national Healthcare-Associated
Infections Surveillance Programme, following the methodology recommended by the HAI-Net, European Centre for
Disease Prevention and Control Program (ECDC).
Results: One hundred sixty eight SSIs were detected in total, including 163 deep SSIs (SSI-D). The total SSI
incidence rate was 1.1%, but in hip prosthesis: 1.2%, in knee prosthesis: 1.3%, for open reduction of fracture (FX):
1.3%, for close reduction of fracture (CR): 1.5, and 0.8% for other procedures. 64% of SSI-D cases required
rehospitalisation. A significantly reduction in incidence was found only after fracture reductions: FX and CR,
respectively 2.1% vs. 0.7% (OR 3.1 95%CI 1.4–6.6, p < 0.01) and 2.1 vs. 0.8% (OR 2.4 95%CI 1.0–5.9, p < 0.05). SSI-Ds
were usually caused by Gram-positive cocci, specially Staphylococcus aureus, 74 (45.7%); Enterobacteriaceae bacillis
accounted for 14.1% and Gram-negative non-fermenting rods for 8.5%.
Conclusions: The implemented SSI prevention plan demonstrated a significant decrease from 2.1 to 0.7% in SSI-D
incidence only in fracture reductions, without changes in epidemiology SSI incidence rates in other procedures.
Depending on the epidemiological situation in the ward, it is worthwhile to surveillance of SSIs associated to
different types of orthopaedic surgery to assess the risks of SSI and take preventive measures.
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Introduction
In the European Union, there is a great diversity with
regard in the practices of control and employment of
staff for infection control teams. In many countries, in-
fection surveillance programmes struggle with human
resource shortages and strong local cultural conditions
[1]. Poland, located in Central and Eastern Europe
(CEE), began to implement a system of surveillance of
healthcare-associated infections (HAIs) after the political
transformation of 1989. Prior to that, there were no
organizational structures or mechanisms allowing to de-
tect, qualify or prevent HAIs; and any attempts to start
debating this issue in the public sphere ended in failure.
Legal regulations providing the foundations for an infec-
tion control system did not come into existence until
2001. Therefore, in Poland, the HAI surveillance system
is relatively young, and, given no tradition of HAI con-
trol and a deeply rooted uncertainty regarding this field,
the conditions are not favourable for a continuous, ac-
tive surveillance or even to registration of HAIs. It is also
substantiated by Allerberger et al. [2] who state that, in
CEE, as well as publicly available information on epi-
demiological methods and indicators, are often insuffi-
cient. This is corroborated by Ider et al. [3] in their
study of how infection control systems function in the
former Soviet bloc. They found weak commitment, lack
of resources, poor specialist knowledge and insufficient
reporting or publishing of information on HAI epidemi-
ology. Additionally, the CEE countries exhibit enormous
differences with regard to legislation, structural elements
and indicators of the methods for infection control and
prevention [2].
Also, according to a report on HAIs by WHO (for
1995–2010), in low- and middle-income countries, regu-
lar HAI surveillance can prove difficult. In the report,
our region, i.e. Central and Eastern Europe, is repre-
sented only by Lithuania and Latvia, as well as Serbia
(which is not part of the EU) [4]. In Poland, there are no
clear or straightforward rules of conduct in surveillance
and there is no obligation to provide information on in-
fections to the public, hence, the data on Polish hospitals
are scarce, which may confirm the thesis put forward by
the authors of the WHO report on difficulties in imple-
menting HAI surveillance.
Zingg et al. have identified ten key elements essential
for an effective infection control in the day-to-day
practice of every hospital. They are, among others,
organization of infection control structures at the hos-
pital level; staff: nurses’ workload and forms of employ-
ment; correct application of guidelines; education and
practice; multimodal and multidisciplinary prevention
programmes, positive organizational culture and audit
and feedback [5]. Hence, a meaningful impulse for the
adoption of activities associated with infection control
can arise in the form of the hospital’s efforts to carry out
accreditation, done by an external entity. In Poland, ac-
creditation is voluntary and free of charge and carried
out by a unit run by the Ministry of Health.
The objective of this study was to analyse the impact
of infection control and prevention activities in patients
with locomotive organ diseases treated surgically and
the implementation of “perioperative control card (peri-
operative checklist)” which was part of the hospital’s
preparation for accreditation. The authors and the Infec-
tion Control Team (ICT) of the investigated hospital, in
their previous analysis of research material from 2009 to
2013 [6], indicated a problem of surprisingly high SSI in-
cidence rate in surgical patients and the urgent need for
action concerning the prevention and control of SSIs. In
2014, the hospital was preparing, for the first time, to
undergo the process of accreditation and the ICT de-
cided to, at the same time, implement a series of inter-
ventions that should significantly improve patient safety;
hence, the analysed material was divided into two time
periods: years 2009–2013 (before the accreditation) and
years 2014–2018 (after the accreditation).
Material and methods
The investigated trauma and orthopaedics ward has 40
beds and is located in southern Poland. The hospital has
its own microbiological laboratory. In the hospital, since
2001, there has been an active Infection Control Team
which consists of a doctor, who is employed on 1/3 full-
time equivalent basis, and 4 full-time nurses. Active sur-
veillance of surgical site infections was introduced in the
examined department in 2008.
In compliance with The International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM) and with the methodology of the National Health-
care Safety Network (NHSN), the operations performed
have been divided into: hip arthroplasties (HPRO), knee
arthroplasties (KPRO), and other musculoskeletal
surgeries: open (FX) and closed (CR) reduction of frac-
ture, knee arthroscopy (KART) and removal of fixation
device (UZ) (Table 1). Patients are admitted both elec-
tively and emergently. In the study period, emergencies
constituted 42.8% of CRs, 30.1% of FXs, 8.0% of UZs,
3.9% of ARTKs, 2.9% of HPROs, 1.3% of KPROs, and
2.3% of others. A single dose of cephazolin was applied
in preoperative antibiotic prophylaxis at a dose of 1 or 2
g i.v. (according to body mass) in the operating room.
For HPRO and KPRO, prophylaxis with cephazolin was
continued every 8 h for 24 h.
The hospital in which the research was carried out par-
ticipates in a voluntary nationwide system of active HAIs
monitoring, in accordance with the methodology of the
Healthcare-Associated Infections Surveillance Network
(HAI-Net), European Centre for Disease Prevention and
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Control (ECDC) [7]. In 2008–2012, infections were de-
tected, qualified and registered according to the defini-
tions by the National Healthcare Safety Network (NHSN)
[8], which are in line with the ECDC definitions [7, 9].
The SSIs were qualified as superficial / deep incisional or
organ/space. The follow-up period was 30 days for the
superficial SSIs, and 90 days for deep or organ/space infec-
tions following arthroplasties. Due to the predominance of
deep incisional SSIs (SSI-D), the authors have decided that
only this group will undergo detailed analysis. The postop-
erative follow-up visits take place 6 weeks after HPRO and
KPRO, in other cases: 2 or 3 days after discharge.
The results of the observation were divided into two
time periods: years 2009–2013 (first period) and years
2014–2018 (second period). In 2013, works have com-
menced to prepare the hospital and the examined de-
partment for the process of accreditation. In the
framework of this development, in 2014, a perioperative
checklist was introduced in the ward under investigation,
which inspected the execution of procedures, including
the newly-implemented practices, among others:
(1) bathing the patient prior to surgery with antiseptic
soap,
(2) changing bed linen and the patient’s underwear
immediately before surgery,
(3) operative field hair removal immediately before
surgery using surgical clippers – without the use of
blades,
(4) surgical hand hygiene according to the WHO
recommendations,
(5) disposable surgical draping,
(6) the application of antiseptic to the edges of the
wound before stitching the skin,
(7) giving systematic (every 6 months) feedback
concerning the epidemiology and microbiology of
infections.
The ward was granted a positive Accreditation Certifi-
cate in 2014, thus, this year became the basis for the
comparison of the results from the period before and
after accreditation.
To compare both periods, the choice was made to
examine the SSI incidence rate and analyse variables,
such as: waiting time for surgery in the ward, duration
of stay in the ward, number of days from surgery to SSI
detection, the number of SSIs detected after discharge.
Additionally, demographics of surgical patients, their age
and genders were also provided. Incidence rate was cal-
culated as the number of SSI cases per 100 operations.
Statistical analysis of the collected material employed
the IBM SPSS (SPSS – Statistical Package for the Social
Sciences) STATISTICS 24 (Armonk, NY, USA) and
Microsoft Excel (Microsoft Office 2016, Redmond, WA,
USA) software. Statistical analysis was carried out with
the use of basic statistical parameters, i.e. mean, 95%
confidence intervals for the mean, median, and standard
deviation. The risk of developing SSI-D in particular
types of surgeries was compared for the two analysed
periods by calculating the odds ratio (OR). In order to
compare the frequency of occurrence of the variants of
the qualitative trait, Pearson’s chi-square test of inde-
pendence was used, Fisher’s exact test was employed for
variables of small numbers and the ANOVA test for
quantitative variables. The level of significance was p <
0.05. The use of data was approved by the Bioethical
Committee of the Jagiellonian University (No. KBET/
122.6120.118.2016 from May 25, 2016). All the data en-
tered into the electronic database and analyzed in this
study were previously anonymized.
Our experiences from the previous years have already
been partly discussed, but those discussions concerned
different types of infections and patient populations [6].
Results
The overall number of subjects included in the study,
during the entire 10-year period, amounted to 15,678
surgical patients. In total, 272 different HAIs were de-
tected in various types of procedures, of which 168
(62%) were SSIs, including 163 SSI-D, i.e. 98% of all SSIs.
HAI incidence rate amounted to 1.7%, SSI incidence was
1.1% (SSI-D 1%). The first symptoms of SSI-D were gen-
erally observed 37 days after surgery (95% CI 29.8–44.9),
and the majority of SSI-D cases, i.e. One hundred four
Table 1 The list of surgeries and ICD-9 codes
Code Operative procedures: ICD-9
HPRO Hip Prosthesis (HPRO): 00.70–00.73; 00.85–00.87; 81.51–81.53.
KPRO Knee Prosthesis (KPRO): 00.80–00.84; 81.54; 81.55.
FX Open Reduction of Fracture (FX): 79.21; 79.22; 79.25; 79.26; 79.31; 79.32; 79.35; 79.36; 79.51; 79.52; 79.55; 79.56.
CR Closed Reduction of Fracture with Internal Fixation (CR): 79.11–79.18; 79.191–79.194
UZ Removal of Fixation Device (UZ): 78.6
KART Knee Arthroscopy (KART): 80.26
OTHER Orthopaedic surgery other than HPRO, KPRO, FX, CR, ZU, KART
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people (64.2%), required rehospitalisation – the diagno-
sis of SII-D was made after the patient was discharged
from hospital. In the analysis of differences between the
two periods studied, no statistical differences were found
in SSI-D incidence in HPRO (p = 0.740), KPRO (p =
0.068) and in KART (p = 0.232) and UZ (p = 0.530) pro-
cedures. A significantly lower incidence was found after
fracture reductions: FX (27 before and 10 cases of SSI-D
after intervention) and CR (19 before and 6 cases of SSI-
D after intervention), SSI-D incidence were respectively
2.1% vs. 0.7% (OR 3.1 95%CI 1.4–6.6, p < 0.01) and 2.1
vs. 0.8% (OR 2.4 95%CI 1.0–5.9, p < 0.05). Among the
other elements under investigation, the patient age chan-
ged significantly: in HPRO, it increased from the initial
67 years to 70 years and, in KART, it decreased from 35
years to 33 years. There was a significant increase
concerning the proportion of men in HPRO, from 35.3
to 41.9%, and in KART, from 61.9 to 69.8%. The
organization of work in the ward expressed in duration
of hospitalization have changed significantly, especially
for HPRO, but the extent of changes was small: 1 day for
HPRO, from 13 days before to 12 days after intervention,
2 days for fracture reduction from 10 and 8 days before
to respectively 8 and 6 days after intervention, and also
2 days for KART, from 5 days before to 3 days after
intervention (Table 2).
Among the SSI-D observed, 10.4% of the cases were not
diagnosed microbiologically: no material for microbio-
logical testing was collected in 9 cases, the aetiological fac-
tor could not be isolated from the materials (wound swabs
and/or blood) in 8 cases. The remaining cases were
dominated by Gram-positive cocci, specially Staphylococ-
cus aureus, 74 (45.7%), and coagulase-negative staphylo-
cocci; rods of the family Enterobacteriaceae accounted for
14.1% and Gram-negative non-fermenting rods for 8.5%
(Table 3).
Discussion
The results obtained in this study were divided into two
time periods: years 2009–2013 (first period – before ac-
creditation) and years 2014–2018 (second period – after
accreditation). The actions implemented – a multimodal
strategy – turned out not to be fully effective, since a
significant fall in the incidence was obtained in only one
category of treatments, i.e. both open and closed reduc-
tions of fractures, where the incidence was significantly
decreased by 3 and 2.5 times. However, the fall in that
single category was still a significant accomplishment for
the investigated department, as these surgeries were
most often performed. In the previous analyses by
Wałaszek et al. [6], in 2008–2012, in the same depart-
ment, FX incidence was 2.6–4.1%. In the literature, there
are no other reports on the scale of this phenomenon in
Polish trauma and orthopaedics wards. Furthermore,
there are no reports from Europe on the incidence rate
concerning infections associated with FX. In American
NHSN research of 2006–2008 [10], the average SSI inci-
dence associated with FX ranged from 1.1 to 3.4% de-
pending on the presence of SSI risk factors, such as:
duration of operation, ASA score, the degree of cleanli-
ness of the operative field. A similar observation
concerns CR procedures, for which in the studied de-
partment in 2008–2012, SSI incidence was 1.2–4.8% [6].
The nature of the procedure – no exposure of open tis-
sues to external factors – and the fact that these proce-
dures involved closed fractures, in which stabilization
was introduced percutaneously, may indicate a close re-
lationship between the occurrence of these infections
and the moment of their implementation. It seems that
the very labelling of these infections as a separate popu-
lation in targeted surveillance directed the attention of
the investigated department to the problem of SSI and
resulted in reducing the number of SSIs. In the litera-
ture, data concerning the problem of SSI in such surger-
ies has not been touched upon.
On the other hand, the observed total incidence of 1%
is a significantly good result considering previous Polish
reports concerning SSI in orthopaedic surgery, e.g. in
Sosnowiec, the SSI incidence was 6.6% [11], and 2.6% in
Cracow [12]. However, multi-centre data are needed to
give a more complete picture of the situation and allow
us to draw comparisons. Rational inference is limited,
given the lack of data on the SSI epidemiology in Polish
trauma and orthopaedics wards, and considerable dis-
crepancies in the epidemiological results. Therefore, it is
recommended to implement a broad and unified HAI
surveillance programme, including SSIs, which would in-
volve a large number of entities, also in Poland.
A research on European Union countries conducted by
the ECDC in 2008–2009 confirms the differences in the
incidence rate between various countries after HPRO and
KPRO procedures; e.g. for HPRO, the lowest rate was re-
corded in the UK and Lithuania (0.3–0.4%), and the high-
est one in Norway and Malta (2.8–3.8%) [13]. The
discrepancies are probably associated with the sensitivity
of the method, as the presumed high SSI detection in
Norway, with the organization of work and the whole
healthcare system, as well as with the flow of information
between different participants of surveillance systems,
which is connected with infection detection in post-
discharge care. At the same time, the risk of exposure to
SSI following HPRO and KPRO observed in the examined
ward for several years reflects the expected level of risk,
i.e. it is comparable to the average obtained in the Euro-
pean HAI-Net programme. Also, the microbial aetiology
does not differ from the reports of other authors [14].
Unfortunately, the data presented are not so optimis-
tic. Our attention is drawn to the dominance of one of
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the forms of SSI, that is, the lack of superficial infec-
tions, despite the fact that they should make up – in
the case of HPRO and KPRO – around 50–60% of
cases [14]. At this point, two hypotheses can be
made, one suggesting SSI-D overdetection, that is, the
tendency to classify cases incorrectly, the other indi-
cating too low detection of superficial SSIs. Therefore,
it is very likely that the real SSI incidence is even 2
times higher. The investigated hospital does not con-
duct any procedures with respect to process valid-
ation regularly, either in terms of the correctness of
procedure performance or as regards the correctness
of infection classification. In the authors’ opinion, it is
the most important element concerning infection con-
trol that currently requires implementation in the
study hospital.
Table 2 Incidence rate of deep incisional surgical site infections (SSI-D) considering age of patients, waiting time for surgery in days,
duration of stay in the ward in days, number of days from surgery to SSI detection, detection before or after discharge from
hospital, gender of patients in HPRO and KPRO endoprosthesis surgery in 2009–2013 vs 2014–2018
Operation type Endoprosthesis Fracture reduction Knee arthroscopy, removal of
fixation device and others



























1491 1224 347 500 1303 1356 898 724 637 669 655 588
Number of SSI-D 16 16 4 9 27 10 19 6 6 3 5 5
Incidence rate (%) 1,1 1,3 1,2 1,8 2,1 0,7 2,1 0,8 0,9 0,4 0,8 0,9
OR (95%CI) 1.2 (0.61 to 2.45) 1.6 (0.48 to 5.15) 0.4 (0.17 to 0.73) 0.4 (0.15 to 0.97) 0.5 (0.12 to 1.90) 1.1 (0.32 to 3.87)
Fisher’s test; OR
(95%CI)
p = 0.740; p = 0.068; p < 0.01; p < 0.05; p = 0.232; 2.1 (0.5–
8.4)
p = 0.530; 0.9 (0.3–
3.2)
Waiting time for operation in the ward [days]
Median (Me); SD 3 (2); 4,1 3 (2); 4,5 2 (2); 2,6 3 (2); 3,7 3 (2); 4,1 3 (2); 4,3 2 (1); 3,6 2 (1); 2,8 2 (1); 2,0 1 (1); 1,2 2 (1); 5,1 2 (1); 3,9
ANOVA (p) p = 0,049 p = 0.383 p = 0.641 p = 0,048 p < 0.05 p = 0.117
Duration of stay in the ward [days]










8 (6); 7,3 8 (7); 6,8 6 (5); 5,2 4 (3); 3,4 4 (3); 2,4 5 (3); 9,0 3 (2); 4,9
ANOVA (p) p = 0,047 p = 0.543 p < 0.001 p < 0.001 p = 0.186 p < 0.001
Number of days from surgery to SSI detection
























ANOVA (p) p = 0.840 p = 0.627 p = 0.617 p = 0.293 p = 0.919 p = 0.876
SSI-D: diagnosis mode [n]
Before discharge 5 (31,3) 8 (50,0) 1 (25,0) 4 (44,4) 12 (46,2) 1 (11,1) 2 (10,5) 3 (50,0) 2 (33,3) 0 (0,0) 3 (60,0) 2 (40,0)
After discharge 11 (68,7) 8 (50,0) 3 (75,0) 5 (55,6) 14 (53,8) 8 (88,9) 17 (89,5) 3 (50,0) 4 (66,7) 3 (100) 2 (40,0) 3 (60,0)
Fisher’s test; OR
(95%CI)
p = 0.238; 0.5 (0.11–
1.92)
p = 0.636; 0.4 (0.03–
5.71)
p = 0.066; 6.9 (0.75–
62.96)
p = 0.070; 0.1 (0.01–
1.03)
p = 0.417; n/a p = 0.50; 2.3 (0.18–
28.26)
Patient age [years]












































































p < 0.001; 1.3 (1.13–
1.54)
p = 0.082; 0.8 (0.61–
1.13)
p = 0.267; 1.1 (0.90–
1.23)
p = 0.129; 1.1 (0.93–
1.37)
p < 0.01; 1.4 (1.13–
1.79)
p = 0.173; 1.1 (0.89–
1.41)
HPRO Hip Prosthesis, KPRO Knee Prosthesis, FX Open Reduction of Fracture, CR Closed Reduction of Fracture with Internal Fixation, KART knee arthroscopy, UZ
removal of fixation device, OR Odds Ratio, SSI-D deep incisional surgical site infections, SD standard deviation, Me median, n/a not available;
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An interesting observation, made possible by this ana-
lysis, can be done as regards patient demographics. A re-
view of European data indicates that Polish patients are
significantly younger (67 years) than the average patient
population operated for HPRO and KPRO in Europe:
median of 72 years. Also other Polish reports confirm
this observation, in studies conducted in two Polish
orthopaedic centres in 2005, the median ages were 68
and 67 years [15]. These results may suggest that inhabi-
tants of other European countries enjoy better health
than people in Poland, who require surgical intervention
5 years earlier, on average. This fact is even more dis-
turbing when data from OECD from 2017 is taken into
consideration, since the average waiting time for HPRO
in Poland was 405 days, while, for example in the
Netherlands, it is 42 days [16].
This retrospective study has some limitations. Firstly,
the research involves only one centre. Secondly, in the
period studied, despite participation in the multicenter
programme, the surveillance of infection method was
not validated, hence, its sensitivity is not known in this
particular case.
Conclusion
The introduction of multimodal and multidisciplinary
SSI prevention and epidemiology programmes in 2014
has resulted in lower SSI incidence rates in some types
of orthopaedic operations. This trend was most strongly
visible following FX and CR fracture reductions. After
HPRO, KPRO and other procedures, a stable, expected
level of SSI incidence was maintained. The results
described confirm the possibility of implementing an
infection surveillance system also throughout Poland.
Making this system stronger and encouraging its partici-
pants to make the results public can reinforce the re-
gional and national surveillance systems. Especially
combining the tasks of an infection control team with
preparation for accreditation allows effective implemen-
tation of infection control practices. Such an approach,
encompassing structural elements and indicators of in-
fection prevention and control, integrating multimodal
and multidisciplinary solutions, make it possible to
strengthen the organizational culture resulting in the re-
duction of SSI risk. Problems associated with improving
the hospital infection surveillance systems probably
affect many other Polish trauma and orthopaedics wards,
hence such active SSI surveillance should be adopted by
other hospitals in Poland.
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